ENTITY
Zylox-Tonbridge Medical Technology

Zylox-Tonbridge Medical Technology (2190 HK)

57
Analysis
Health Care • China
Zylox-Tonbridge Medical Technology is a medical technology company dedicated to the innovative research, development, manufacturing, and commercialization of neurovascular and peripheral vascular interventional devices. Its product portfolio includes devices such as the Thrombite Clot Retriever Device, Ultrafree Drug Coated PTA Balloon Catheter, and Zenflex Peripheral Stent System. The company was founded in 2012 and is headquartered in Hangzhou, China.
more
•22 Jun 2021 23:05

Zylox-Tonbridge IPO: Living On

Zylox-Tonbridge has launched an HKEx IPO to raise net proceeds of $300 million at the mid-point of the IPO price range. Overall, we believe that...

Logo
600 Views
Share
•22 Jun 2021 15:30

Zylox-Tonbridge (å½’åˆ›é€šę”„) IPO: Clear Upside Thanks to Comprehensive Coverage

With its comprehensive product coverage in the neuro- and peripheral interventional device segment, we think there's a clear valuation upside for...

Logo
535 Views
Share
bullish•Full Truck Alliance
•20 Jun 2021 09:57

ECM Weekly (20th June 2021) - Didi, Nayuki, Soulgate, Hutchmed, Full Truck, CTOS, Cloud Village

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
•15 Jun 2021 15:50

Zylox-Tonbridge (å½’åˆ›é€šę”„) Pre-IPO: Competition Is the Key Concern

Zylox-Tonbridge is a leading neuro- and peripheral vascular interventional device company with a comprehensive product coverage. It has two main...

Logo
551 Views
Share
•14 Apr 2021 17:29

Shanghai HeartCare Medical IPO Initiation: Surviving Strokes

HeartCare is set to pre-market an HKEx IPO to raise $300 million this quarter, according to press reports. Overall, we believe that HeartCare’s...

Logo
566 Views
Share
x